344 Results for "

epidermal

" in MedChemExpress (MCE) Product Catalog:
Products (344)

344 Results for "epidermal" in MCE Product Catalog:

  • Targets Recommended:
113
113 Publications Verification
Cat. No.: HY-18723
CAS No.: 448947-81-7
Yoda 1 is a potent and selective Piezo1 agonist. Yoda 1 activates purified Piezo1 channels. Yoda 1 potently inhibits macropinocytosis induced by epidermal growth factor (EGF). Yoda 1 enhances Ca 2+ influx followed by activation of the calcium-activated potassium channel KCa3.1 and inhibition of Rac1 activation .
loading...
    loading...
103
103 Cited Publications
Cat. No.: HY-P7109
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuEGF; Pro-epidermal growth factor; Urogastrone
Species:  
Source:  
loading...
    loading...
55
55 Cited Publications
Cat. No.: HY-P9905
CAS No.: 205923-56-4
Synonyms: C225; IMC-C225

Research Areas:  

Cancer

Cetuximab (C225) is a human IgG1 monoclonal antibody that inhibits epidermal growth factor receptor (EGFR), with a Kd of 0.201 nM for EGFR by SPR. Cetuximab has potent antitumor activity .
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-P7067
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rMuEGF; Pro-epidermal growth factor; Urogastrone
Species:  
Source:  
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-138298A
CAS No.: 1826843-81-5
Purity:  99.58%
Synonyms: T-DXd; DS-8201; DS-8201a
Trastuzumab deruxtecan (DS-8201a) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-138298
CAS No.: 1826843-81-5
Purity:  98.90%
Synonyms: T-DXd (solution); DS-8201 (solution); DS-8201a (solution)
Trastuzumab deruxtecan (T-DXd; DS-8201a) (solution) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-P7109G
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Pro-epidermal growth factor; EGF; Urogastrone
Species:  
Source:  
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-P9985
CAS No.: 2136633-23-1
Synonyms: RC48
Research Areas:  

Cancer

Disitamab vedotin (RC48) is an antibody-drug conjugate (ADC) comprising a monoclonal antibody against human epidermal growth factor receptor 2 (HER2) conjugated via a cleavable linker to the cytotoxic agent Monomethyl auristatin E (MMAE) (HY-15162), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E). Disitamab vedotin enhances antitumor immunity .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-N0447
CAS No.: 23513-08-8
8-Gingerol can be found in the rhizome of ginger (Z. officinale) and has oral bioactivity. It activates TRPV1, with an EC50 value of 5.0 µM. 8-Gingerol inhibits COX-2 and also suppresses the growth of H. pylori in vitro. Additionally, 8-Gingerol exhibits anticancer, antioxidant, and anti-inflammatory properties by inhibiting the epidermal growth factor receptor (EGFR) and modulating its downstream STAT3/ERK pathway to suppress the proliferation, migration, and invasion of colorectal cancer cells. 8-Gingerol also exerts immunosuppressive effects by inhibiting oxidative stress, inducing cell cycle arrest, promoting apoptosis, and regulating autophagy. Furthermore, 8-Gingerol has cardioprotective effects. 8-Gingerol is promising for research in the fields of cancer, infection, immunosuppression, and cardiovascular diseases.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-P0221
CAS No.: 137061-48-4
Synonyms: Pituitary Adenylate Cyclase Activating Polypeptide 38
PACAP (1-38), human, ovine, rat is a PAC1 receptor agonist. PACAP (1-38), human, ovine, rat binds to PACAP type I receptor, PACAP type II receptor VIP1, and PACAP type II receptor VIP2 with IC50s of 4 nM, 2 nM, and 1 nM, respectively. PACAP (1-38), human, ovine, rat increases the α-secretase activity. PACAP (1-38), human, ovine, rat elevates cytosolic Ca 2+, increases proliferation and increases phosphorylation of extracellular regulates kinase (ERK) and the epidermal growth factor receptor (EGFR). PACAP (1-38), human, ovine, rat demonstrates potent, efficacious, and sustained stimulatory effects on sympathetic neuronal NPY and catecholamine production. PACAP (1-38), human, ovine, rat can be used for neurotrophic and neuroprotective research .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-P7092
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rRtEGF; Pro-epidermal growth factor; Urogastrone
Species:  
Rat
Source:  
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-13314
CAS No.: 781613-23-8
Purity:  99.41%
Synonyms: XL-647; EXEL-7647; KD-019
Target:  

EGFR VEGFR Src

Research Areas:  

Cancer

Tesevatinib (XL-647) is an orally available, blood-brain barrier-penetrant inhibitor of the epidermal growth factor receptor (EGFR). Tesevatinib significantly reduces cellular viability, with IC50 values of 11 nM and 102 nM in GBM12 and GBM6, respectively. Tesevatinib also inhibits HER2 (IC50=16.1 nM), VEGFR2 (IC50=1.5 nM), and Src (IC50=10.3 nM). Tesevatinib can inhibit tumor proliferation and exhibits antitumor activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-N0128
CAS No.: 515-03-7
Sclareol is isolated from Salvia sclarea with anticarcinogenic activity. Sclareol shows strong cytotoxic activity against mouse leukemia (P-388), human epidermal carcinoma (KB) cells and human leukemia cell lines. Sclareol induces cell apoptosis .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P70590
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Pro-epidermal growth factor; epidermal growth factor; EGF
Species:  
Source:  
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-107364
CAS No.: 1952236-05-3
Purity:  99.81%
Synonyms: Mol 211
Target:  

EGFR PI3K

Research Areas:  

Cancer

MTX-211 (Mol 211) is a dual inhibitor of EGFR and PI3K with IC50 values of <100 nM. MTX-211 can be used for the research of cancer and other diseases .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-114456
CAS No.: 124579-05-1
Purity:  98.07%
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

Ganglioside GM3 is a precursor of a-, b-, and c-series gangliosides, interacts with transmembrane receptors such as the epidermal growth factor and insulin receptors, and regulates receptor functions by creating a specialized lipid environment. Ganglioside GM3 is synthesized by GM3 synthase and can be used for the research of hypercholesterolemia .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P70590AF
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Pro-epidermal growth factor; epidermal growth factor; EGF
Species:  
Source:  
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P72989
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: epidermal growth factor receptor; EGFR; ERBB; ERBB1; HER1
Species:  
Source:  
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P72987
Purity:  ≥ 75%, as determined by reducing SDS-PAGE.
Synonyms: epidermal growth factor receptor; EGFR; ERBB; ERBB1; HER1
Species:  
Source:  
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-13984
CAS No.: 1421373-62-7
Purity:  99.51%
Synonyms: EGFR mutant-IN-3
Research Areas:  

Cancer

NT-1 (EGFR mutant-IN-3) is a potent mutant EGFR inhibitor and an analog of Osimertinib (HY-15772). This mutant EGFR inhibitor suppresses FGFR WT with an IC50 of 0.4 nM. NT-1 also inhibits EGFR L858R, EGFR Exon 19 deletion and EGFR T790M. NT-1 exerts deeper inhibition on p-EGFR and p-ERK, and induces tumor cell apoptosis. NT-1 can be used in colorectal cancer research .
loading...
    loading...